Drug Name |
Crofelemer |
Drug ID |
BADD_D00536 |
Description |
Crofelemer, previously known as the investigational drug SP-303, is a novel proanthocyanidin purified from the bark latex of the Amazonian Croton tree Croton lechleri. It is marketed under the brand name Fulyzaq and indicated for the symptomatic treatment of non-infectious diarrhea in adult patients with HIV/AIDS who are taking antiretroviral therapy. |
Indications and Usage |
For the symptomatic treatment of non-infectious diarrhea in adult patients with HIV/AIDS who are taking antiretroviral therapy. |
Marketing Status |
Prescription |
ATC Code |
A07XA06 |
DrugBank ID |
DB04941
|
KEGG ID |
D03605
|
MeSH ID |
C546704
|
PubChem ID |
36511
|
TTD Drug ID |
D09VXM
|
NDC Product Code |
70564-802; 66039-854 |
Synonyms |
crofelemer | Fulyzaq |